Abstract:OBJECTIVEHepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatic arterial chemoembolization transcatheter (TACE) is one of the main treatment methods for liver cancer. However, the long-term therapeutic effect of HCC after TACE is still unsatisfactory, postoperative recurrence and metastasis rate is still very high. Furthermore, TACE operation due to liver cancer tissue ischemia and hypoxia will lead to up-regulation of vascular endothelial growth factor (VEGF) expression. In the current study, we investigated the effects of suppressed VEGF on HCC and its molecular mechanism provided a basis for targeting angiogenesis.MATERIALS AND METHODSWe established rabbits primary HCC model by in situ embedding the VX2 subcutaneous transplantation tumor. Conventional Seldinger femoral artery and hepatic artery catheterization method were used to select the catheter over the tumor-bearing hepatic artery. The different groups were divided into TACE operation, and the experimental group was performed with the VEGF-siRNA molecular preparation in the catheter. 64-slice spiral CT were used to perfusion imaging of liver cancer model before and after TACE operation. We further assessed the efficiency of VEGF silencing and its influence on VX2 cells. The expression of VEGF mRNA and protein were detected by RT-PCR and Western blotting, respectively. Intratumoral microvessel density (MVD), VEGF and CD34 were evaluated by immunohistochemistry. We detected the cell apoptotic by immunofluorescence and flow cytometry.RESULTSOur findings indicated that VEGF-siRNA-2# could effectively suppress the expression of VEGF expression, inhibited the proliferation capability and promoted apoptosis of VX2 cells in vitro. Silencing of VEGF expression also suppress HCC tumor growth and reduce HCC angiogenesis in rabbits primary HCC model in vivo. Furthermore, We found that phosphoinositide 3-kinase (PI3K) and protein kinase B (AKT) activation were considerably reduced while inhibition VEGF expression in VX2 cells.CONCLUSIONSOur data demonstrated that VEGF silencing could suppress cells proliferation, promote cells apoptosis and reduce HCC angiogenesis through inactivation of VEGF/PI3K/AKT signaling pathway.

Effects of VEGF-A on vasculogenic mimicry in human hepatocellular carcinoma cells in vitro

[Autocrine Effect of Vascular Endothelial Growth Factor on the Proliferation of HaCaT Cells].

Relationship of HDGF or VEGF expression with hepatocellular carcinoma angiogenesis:report of 108 cases

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

The effect and mechanism of epithelial growth factor receptor (EGFR)in inducing vasculogenic mimicry formation

VEGF Induce Vasculogenic Mimicry of Choroidal Melanoma through the PI3k Signal Pathway

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Vasculogenic Mimicry Formation Difference and Its Mechanism in Human Hepatocellular Carcinoma Cell Lines with Different Metastatic Potentials

Searching for Vasculogenic Mimicry-Associated Differentially Expressed Genes in Human Hepatocellular Carcinoma Cell Line MHCC97 Using Functional Grouping Cdna Microarray

Inhibitory Effect of Antisense Vascular Endothelial Growth Factor 165 Eukaryotic Expression Vector on Proliferation of Hepatocellular Carcinoma Cells

Expression of Vasculogenic Mimicry-Associated Genes in Human Hepatocellular Carcinoma Cell Lines HCCLM3 and MHCC97-L with Different Metastatic Potentials

Inhibitive effect of angiogenesis inhibitors on vasculogenic mimicry in human hepatocellular carcinoma cell line mhcc97-h in vitro

Expression and significance of CD34 and CD133 in vasculogenic mimicry of hepatocellular carcinoma

HIF-1α Induces VE-cadherin Expression and Modulates Vasculogenic Mimicry in Esophageal Carcinoma Cells

CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway

Hepatocyte Nuclear Factor 4α Inhibits Expression of Vascular Endothelial Growth Factor in Human Hepatocellular Carcinoma Cell Lines and Tube Formation of Human Umbilical Vein Endothelial Cell

Effects of Endothelial Cells Conditioned Medium on the Proliferation and Invasion of Hepatocellular Carcinoma Cells

Advancement of the relationship between vascular endothelial growth factor receptors and angiogenesis of hepatocellular carcinoma

Effect of a 630 nm laser on vasculogenic mimicry in A549 lung adenocarcinoma cells in vitro

HIGH- THROUGHPUT TISSUE MICROARRAY ANALYSIS EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTIOR IN PRIMARY LIVER CANCER AND ITS RELATIONSHIP WITH PROGNOSIS

[Influence of Tumor Microenvironment of Hepatocellular Carcinoma on the Proliferation of Vascular Endothelial Cells and Vascular Angiogenesis Ability].